A new oxidative stress marker in patients with nasal polyposis: Advanced oxidation protein products (AOPP)

B-ENT

Volumn 6, Issue 2, 2010, Pages 105-109

  Veyseller, B ^a   Aksoy, F ^a   Ertas B ^a   Keskin, M ^a   Ozturan O ^a   Yildirim, Yavuz Selim ^a   Bayraktar, F G I ^a   Ozturk H ^b  

^a Haseki Training and Research Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

Advanced Oxidation Protein Products (AOPP); Inflammatory disease; Nasal polyp; Oxidative stress

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; BIOLOGICAL MARKER; PLASMA PROTEIN; REACTIVE OXYGEN METABOLITE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; NOSE POLYP; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; SPECTROPHOTOMETRY; BLOOD; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; BIOLOGICAL MARKERS; BLOOD PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 77956624597     PISSN: 1781782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pawankar R. Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol. 2003;3(1):1-6. (Pubitemid 36159341)
2. Bryson JM, Tasca RA, Rowe-Jones JM. Local and systemic eosinophilia in patients undergoing endoscopic sinus surgery for chronic rhinosinusitis with and without polyposis. Clin Otolaryngol Alleid Sci. 2003;28(1):55-58. (Pubitemid 36286793)
3. Nelson HS. Advances in upper airway disease and allegen immunotherapy. J Allergy Clin Immunol. 2007:119(4): 872-880. (Pubitemid 46527809)
4. Bodamyali T, Stevens CR, Blake DR, Winyard PG. Reactive oygen/nitrogen species and acute inflammation: a physiological process. In: Winyard PG, Blake DR, Evans CH, eds. Free Radicals and Inflammation. Birkhauser-Verlag, Basel Swizerland; 2000:11-16.
5. Doǧru H, Delibaş N, Döner F, Tüz M, Uygur K. Free radical damage in nasal polyp tissue. Otolaryngol Head Neck Surg. 2001;124(5):570-572. (Pubitemid 33733774)
6. Daǧli M, Eryilmaz A, Besler T, Akmansu H, Acar A, Korkmaz H. Role of free radicals and antioxidants in nasal polyps. Laryngoscope. 2004; 114(7):1200-1203. (Pubitemid 38954573)
7. Del Rio D, Serafini M, Pellegrini N. Selected methodologies to assess oxidative/antioxidant status in vivo: a critical review. Nutr Metab Cardiovasc Dis. 2002;12(6):343-351. (Pubitemid 135713176)
8. Witko-Sarsat V, Friendlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49(5): 1304-1313. (Pubitemid 26166404)
9. Massy ZA, Nguyen-Khoa T. Oxidative stress and chronic renal failure: markers and management. J Nephrol. 2002;15(4):336-341.
10. Vissers MC, Winterbourn CC. Oxidative damage to fibronectin I. The effects of the neutrophil myeloperoxidase system and HOC1. Arch Biochem Biophys. 1991;285(1): 53-59.
11. Drake-Lee AB. Pathogenesis of nasal polyps. In: Setipane GA, Lund VJ, Bernstein JM, Tos M, Eds. Nasal polyps: Epidemiology, Pathogenesis and Treatment. Ocean Side Publications, Rhode Island;1997:17-64.
12. Bachert C, Jorissen M, Bertrand B, Khaltaev N, Bousquet J. Allergic Rhinitis and its impact on asthma update (ARIA 2008). The Belgian perspective. B-ENT. 2008;4(4):253-257.
13. Piwowar A, Knapik-Kordecka M, Warwas M. AOPP and its relations with selected markers of oxidative/ antioxidative system in type 2 diabetes mellitus. Diabetes Res Clin Fract. 2007;77(2):188-192. (Pubitemid 46670416)
14. Halliwell B. Oxidants and human disease: some new concepts. FASEB J. 1987;1(5):358-364. (Pubitemid 18049734)
15. Halliwell B, Gutteridge JM, Cross CE. Free radicals, antioxidants and human disease: where are we now? J Lab Clin Med. 1992;119(6): 598-620.
16. Besler ET, Çomoǧlu S. Lipoprotein oxidaton, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis. Nutr Neurosci. 2003;6(3):189-196. (Pubitemid 36656698)
17. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol. 2001;54(3):176-186.
18. Alderman CJ, Shah S, Foreman JC, Chain BM, Katz DR. The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic Biol Med. 2002; 32(5):377-385. (Pubitemid 34178347)
19. Eloy P, Watelet JB, Rombaux P, Daele J, Bertrand B. Management of chronic rhinosinusitis without polyps in adults. B-ENT. 2005;Suppl 1: 65-74. quiz 75-76.
20. Taysi S, Uslu C, Yilmaz A, Aktan B, Atlas E. Lipid peroxidation and some antioxidant enzymes in nasal polyp tissue. Cell Biochem Funct. 2006; 24(5):461-465. (Pubitemid 44379587)
21. Parks RR, Huang CC, Haddad J Jr. Evidence of oxygen radical injury in experimental otitis media. Laryngoscope. 1994;104 (11 Pt 1): 1389-1392. (Pubitemid 24346969)
22. Karlidag T, Ilhan N, Kaygusuz I, Keles E, Yalcin S, Yildiz M. Roles of free radicals, nitric oxide, and scavenging enzymes in nasal polyp development. Ann Otol Rhinol Laryngol. 2005;114(2):122-126. (Pubitemid 40250247)
23. Norlander T, Westrin KM, Fukami M, Stierna P, Carlsoo B. Experimentally induced polyps in the sinus mucosa: a structural analysis of the initial stages. Laryngoscope. 1996;106(2 Pt 1):196-203.
24. Lachance PA, Nakat Z, Jeong WS. Antioxidants: an integrative approach. Nutrition. 2001;17(10): 835-838. (Pubitemid 33001650)
25. Gopalakrishna R, Jaken S. Protein kinase C signaling and oxidative stres. Free Radic Biol Med. 2000;28(9): 1349-1361. (Pubitemid 30621479)